Predictions for Health Tech Innovators: 2023
By Josh Gray What lies ahead for innovative health technologies companies in 2023? Heading into 2022, we predicted a tough year for startups. If anything, we understated the situation: the funding environment is dramatically tougher, with little prospect of relief in the near future. We also anticipated that “early advocates using AI in controlled settings […]
Recent Conference Take-Aways
By Paul Cummings David Clain moderating the Cost and Quality Analytics Panel at FLAACOs Keynote speaker Dr. Anthony Fauci at the 2022 APG Colloquium HDAI recently participated in both the Florida Association of Accountable Care Organizations (FLAACOs) conference in Orlando, FL and the APG (America’s Physician Groups) Colloquium 2022 – America’s Physician Groups in Washington DC. […]
The Next Evolution
By Nidhee Krishnan Nidhee is a product manager with HDAI, who transitioned a year ago from bedside care to healthcare innovation. Prior to this career change, she was in her second year of medical school and was conducting clinical research in parallel. She took a few moments to briefly share with us how her experiences in […]
Moving Beyond a Single Risk Score
05.20.22
Turbulence Ahead for Health Care Startups
12.23.21
The Risk Stratification Index (RSI) is proven again to be a reliable baseline risk predictor
11.03.21 By Paul Manberg How do we get more value out of limited health care dollars? One strategy is to use a risk stratification tool that helps avoid expensive downstream events by identifying which patients should be selected for additional surveillance and earlier intervention if needed. AI-driven predictors that use administrative data are attractive because the data is readily […]
Where are Seniors More Receptive to Telemedicine?
10.12.21
How COVID Has Influenced the Way Medicare Beneficiaries Use Telemedicine
09.14.21
New Research Explores Immuno-oncology Effectiveness for Lung Cancer in Medicare Population
05.21.21 Findings from HDAI and Dana-Farber Cancer Institute Real-world Evidence Study of 20,000 Medicare Patients Shows Shorter Survival Times than Observed in Clinical Trials BOSTON, May 21, 2021 /PRNewswire/ — Health Data Analytics Institute (HDAI) – an innovator in healthcare AI solutions – and researchers at Dana-Farber Cancer Institute today announced publication of findings exploring the effectiveness of immune checkpoint inhibition for […]
Turning Data into Insights for ACOs
03.20.21
